Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells.
Aorta
/ metabolism
Cell Transdifferentiation
/ physiology
Cells, Cultured
Chondrogenesis
/ physiology
Energy Metabolism
/ physiology
Glycerophosphates
/ metabolism
Humans
Hyperphosphatemia
/ metabolism
Muscle, Smooth, Vascular
/ metabolism
Myocytes, Smooth Muscle
/ metabolism
Osteogenesis
/ physiology
Phosphates
/ metabolism
Renal Insufficiency, Chronic
/ metabolism
Signal Transduction
/ physiology
Vascular Calcification
/ metabolism
Bioenergetics
Glycolysis
Mitochondrial respiration
Vascular calcification
Vascular smooth muscle cells
β-Glycerophosphate
Journal
Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
27
12
2019
accepted:
14
05
2020
revised:
12
05
2020
pubmed:
4
6
2020
medline:
13
7
2021
entrez:
4
6
2020
Statut:
ppublish
Résumé
In chronic kidney disease, hyperphosphatemia is a key pathological factor promoting medial vascular calcification, a common complication associated with cardiovascular events and mortality. This active pathophysiological process involves osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells (VSMCs) via complex intracellular mechanisms that are still incompletely understood. Little is known about the effects of phosphate on the bioenergetic profile of VSMCs during the onset of this process. Therefore, the present study explored the effects of the phosphate donor β-glycerophosphate on cellular bioenergetics of VSMCs. Mitochondrial and glycolytic functions were determined utilizing extracellular flux analysis in primary human aortic VSMCs following exposure to β-glycerophosphate. In VSMCs, β-glycerophosphate increased basal respiration, mitochondrial ATP production as well as proton leak and decreased spare respiratory capacity and coupling efficiency, but did not modify non-mitochondrial or maximal respiration. β-Glycerophosphate-treated VSMCs had higher ability to increase mitochondrial glutamine and long-chain fatty acid usage as oxidation substrates to meet their energy demand. β-Glycerophosphate did not modify glycolytic function or basal and glycolytic proton efflux rate. In contrast, β-glycerophosphate increased non-glycolytic acidification. β-Glycerophosphate-treated VSMCs had a more oxidative and less glycolytic phenotype, but a reduced ability to respond to stressed conditions via mitochondrial respiration. Moreover, compounds targeting components of mitochondrial respiration modulated β-glycerophosphate-induced oxidative stress, osteo-/chondrogenic signalling and mineralization of VSMCs. In conclusion, β-glycerophosphate modifies key parameters of mitochondrial function and cellular bioenergetics in VSMCs that may contribute to the onset of phenotypical transdifferentiation and calcification. These observations advance the understanding of the role of energy metabolism in VSMC physiology and pathophysiology of vascular calcification during hyperphosphatemia. KEY MESSAGES: β-Glycerophosphate modifies key parameters of mitochondrial respiration in VSMCs. β-Glycerophosphate induces changes in mitochondrial fuel choice in VSMCs. β-Glycerophosphate promotes a more oxidative and less glycolytic phenotype of VSMCs. β-Glycerophosphate triggers mitochondrial-dependent oxidative stress in VSMCs. Bioenergetics impact β-glycerophosphate-induced VSMC calcification.
Identifiants
pubmed: 32488546
doi: 10.1007/s00109-020-01925-8
pii: 10.1007/s00109-020-01925-8
pmc: PMC7343738
doi:
Substances chimiques
Glycerophosphates
0
Phosphates
0
beta-glycerophosphoric acid
WWH06G87W6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
985-997Références
Lang F, Leibrock C, Pelzl L, Gawaz M, Pieske B, Alesutan I, Voelkl J (2018) Therapeutic interference with vascular calcification-lessons from klotho-hypomorphic mice and beyond. Front Endocrinol (Lausanne) 9:207
Vervloet M (2019) Modifying phosphate toxicity in chronic kidney disease. Toxins (Basel) 11. https://doi.org/10.3390/toxins11090522
Hruska KA, Mathew S, Lund R, Qiu P, Pratt R (2008) Hyperphosphatemia of chronic kidney disease. Kidney Int 74:148–157
pubmed: 18449174
pmcid: 2735026
Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, Hostetter TH, Melamed ML (2010) Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol 5:1064–1071
pubmed: 20378645
pmcid: 2879313
Voelkl J, Lang F, Eckardt KU, Amann K, Kuro OM, Pasch A, Pieske B, Alesutan I (2019) Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci 76:2077–2091
pubmed: 30887097
pmcid: 6502780
Voelkl J, Cejka D, Alesutan I (2019) An overview of the mechanisms in vascular calcification during chronic kidney disease. Curr Opin Nephrol Hypertens 28:289–296
pubmed: 30985336
Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109:697–711
pubmed: 21885837
pmcid: 3249146
Lang F, Ritz E, Voelkl J, Alesutan I (2013) Vascular calcification--is aldosterone a culprit? Nephrol Dial Transplant 28:1080–1084
pubmed: 23476041
Voelkl J, Luong TT, Tuffaha R, Musculus K, Auer T, Lian X, Daniel C, Zickler D, Boehme B, Sacherer M et al (2018) SGK1 induces vascular smooth muscle cell calcification through NF-kappaB signaling. J Clin Invest 128:3024–3040
pubmed: 29889103
pmcid: 6025998
Lang F, Ritz E, Alesutan I, Voelkl J (2014) Impact of aldosterone on osteoinductive signaling and vascular calcification. Nephron Physiol 128:40–45
pubmed: 25377380
Dai L, Schurgers LJ, Shiels PG, Stenvinkel P (2020) Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrol Dial Transplant 35:ii31–ii37
pubmed: 32162665
pmcid: 7066546
Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS, Rosenblatt KP, Kuro OM et al (2013) Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 123:812–822
pubmed: 23298834
pmcid: 3561808
Henze LA, Luong TTD, Boehme B, Masyout J, Schneider MP, Brachs S, Lang F, Pieske B, Pasch A, Eckardt KU et al (2019) Impact of C-reactive protein on osteo-/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells. Aging (Albany NY) 11:5445–5462
Voelkl J, Tuffaha R, Luong TTD, Zickler D, Masyout J, Feger M, Verheyen N, Blaschke F, Kuro OM, Tomaschitz A et al (2018) Zinc inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-kappaB. J Am Soc Nephrol 29:1636–1648
pubmed: 29654213
pmcid: 6054342
Schelski N, Luong TTD, Lang F, Pieske B, Voelkl J, Alesutan I (2019) SGK1-dependent stimulation of vascular smooth muscle cell osteo-/chondrogenic transdifferentiation by interleukin-18. Pflugers Arch 471:889–899
pubmed: 30706178
pmcid: 6533237
Alesutan I, Tuffaha R, Auer T, Feger M, Pieske B, Lang F, Voelkl J (2017) Inhibition of osteo/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor. J Hypertens 35:523–532
pubmed: 27984337
Chiong M, Cartes-Saavedra B, Norambuena-Soto I, Mondaca-Ruff D, Morales PE, Garcia-Miguel M, Mellado R (2014) Mitochondrial metabolism and the control of vascular smooth muscle cell proliferation. Front Cell Dev Biol 2:72
pubmed: 25566542
pmcid: 4266092
Jia Y, Wang M, Mao C, Yu F, Wang Y, Xiao R, Jiang C, Zheng L, Xu Q, Zheng M, Fu Y, Hu Q, Kong W (2018) COMP-prohibitin 2 interaction maintains mitochondrial homeostasis and controls smooth muscle cell identity. Cell Death Dis 9:676
pubmed: 29867124
pmcid: 5986769
Yang M, Chadwick AE, Dart C, Kamishima T, Quayle JM (2017) Bioenergetic profile of human coronary artery smooth muscle cells and effect of metabolic intervention. PLoS One 12:e0177951. https://doi.org/10.1371/journal.pone.0177951
doi: 10.1371/journal.pone.0177951
pubmed: 28542339
pmcid: 5438125
Lee SJ, Jeong JY, Oh CJ, Park S, Kim JY, Kim HJ, Doo Kim N, Choi YK, Do JY, Go Y, Ha CM, Choi JY, Huh S, Ho Jeoung N, Lee KU, Choi HS, Wang Y, Park KG, Harris RA, Lee IK (2015) Pyruvate dehydrogenase kinase 4 promotes vascular calcification via SMAD1/5/8 phosphorylation. Sci Rep 5:16577
pubmed: 26560812
pmcid: 4642318
Kim H, Kim HJ, Lee K, Kim JM, Kim HS, Kim JR, Ha CM, Choi YK, Lee SJ, Kim JY, Harris RA, Jeong D, Lee IK (2012) Alpha-lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J Cell Mol Med 16:273–286
pubmed: 21362131
pmcid: 3823291
Ma WQ, Sun XJ, Wang Y, Zhu Y, Han XQ, Liu NF (2019) Restoring mitochondrial biogenesis with metformin attenuates beta-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype via inhibition of PDK4/oxidative stress-mediated apoptosis. Mol Cell Endocrinol 479:39–53
pubmed: 30170182
Zhang P, Li Y, Du Y, Li G, Wang L, Zhou F (2016) Resveratrol ameliorated vascular calcification by regulating Sirt-1 and Nrf2. Transplant Proc 48:3378–3386
pubmed: 27931585
Perez J, Hill BG, Benavides GA, Dranka BP, Darley-Usmar VM (2010) Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor. Biochem J 428:255–267
pubmed: 20331438
pmcid: 3641000
Salabei JK, Hill BG (2013) Mitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation. Redox Biol 1:542–551
pubmed: 24273737
pmcid: 3836280
Yetkin-Arik B, Vogels IMC, Nowak-Sliwinska P, Weiss A, Houtkooper RH, Van Noorden CJF, Klaassen I, Schlingemann RO (2019) The role of glycolysis and mitochondrial respiration in the formation and functioning of endothelial tip cells during angiogenesis. Sci Rep 9:12608
pubmed: 31471554
pmcid: 6717205
Cheng J, Nanayakkara G, Shao Y, Cueto R, Wang L, Yang WY, Tian Y, Wang H, Yang X (2017) Mitochondrial proton leak plays a critical role in pathogenesis of cardiovascular diseases. Adv Exp Med Biol 982:359–370
pubmed: 28551798
pmcid: 5630226
Rich PR, Marechal A (2010) The mitochondrial respiratory chain. Essays Biochem 47:1–23
pubmed: 20533897
Mori D, Matsui I, Shimomura A, Hashimoto N, Matsumoto A, Shimada K, Yamaguchi S, Oka T, Kubota K, Yonemoto S, Sakaguchi Y, Takahashi A, Shintani Y, Takashima S, Takabatake Y, Hamano T, Isaka Y (2018) Protein carbamylation exacerbates vascular calcification. Kidney Int 94:72–90
pubmed: 29716796
Idelevich A, Rais Y, Monsonego-Ornan E (2011) Bone Gla protein increases HIF-1alpha-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler Thromb Vasc Biol 31:e55–e71
pubmed: 21757657
Zhao MM, Xu MJ, Cai Y, Zhao G, Guan Y, Kong W, Tang C, Wang X (2011) Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int 79:1071–1079
pubmed: 21368742
Masuda M, Miyazaki-Anzai S, Keenan AL, Okamura K, Kendrick J, Chonchol M, Offermanns S, Ntambi JM, Kuro OM, Miyazaki M (2015) Saturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity. J Clin Invest 125:4544–4558
pubmed: 26517697
pmcid: 4665795
Green DE, Zande HD (1981) Universal energy principle of biological systems and the unity of bioenergetics. Proc Natl Acad Sci U S A 78:5344–5347
pubmed: 6946475
pmcid: 348741
Hill BG, Benavides GA, Lancaster JR Jr, Ballinger S, Dell’Italia L, Jianhua Z, Darley-Usmar VM (2012) Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol Chem 393:1485–1512
pubmed: 23092819
pmcid: 3594552
Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11:325–337
pubmed: 21508971
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
pubmed: 19460998
pmcid: 2849637
Uebelhoer M, Iruela-Arispe ML (2016) Cross-talk between signaling and metabolism in the vasculature. Vasc Pharmacol 83:4–9
Butler TM, Siegman MJ (1985) High-energy phosphate metabolism in vascular smooth muscle. Annu Rev Physiol 47:629–643
pubmed: 3158271
Mercer JR (2014) Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease. Pharmacol Ther 141:13–20
pubmed: 23911986
Villa-Bellosta R, O’Neill WC (2018) Pyrophosphate deficiency in vascular calcification. Kidney Int 93:1293–1297
pubmed: 29580636
Villa-Bellosta R (2018) Synthesis of extracellular pyrophosphate increases in vascular smooth muscle cells during phosphate-induced calcification. Arterioscler Thromb Vasc Biol 38:2137–2147
pubmed: 30002059
Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 435:297–312
pubmed: 21726199
pmcid: 3076726
Weightman Potter PG, Vlachaki Walker JM, Robb JL, Chilton JK, Williamson R, Randall AD, Ellacott KLJ, Beall C (2019) Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes. Diabetologia 62:187–198
pubmed: 30293112
Muoio DM (2014) Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell 159:1253–1262
pubmed: 25480291
pmcid: 4765362
Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A (2006) Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 99:924–932
pubmed: 17068300
Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13
pubmed: 19061483
Jastroch M, Divakaruni AS, Mookerjee S, Treberg JR, Brand MD (2010) Mitochondrial proton and electron leaks. Essays Biochem 47:53–67
pubmed: 20533900
pmcid: 3122475
Mookerjee SA, Goncalves RLS, Gerencser AA, Nicholls DG, Brand MD (2015) The contributions of respiration and glycolysis to extracellular acid production. Biochim Biophys Acta 1847:171–181
pubmed: 25449966
Kenwood BM, Weaver JL, Bajwa A, Poon IK, Byrne FL, Murrow BA, Calderone JA, Huang L, Divakaruni AS, Tomsig JL, Okabe K, Lo RH, Cameron Coleman G, Columbus L, Yan Z, Saucerman JJ, Smith JS, Holmes JW, Lynch KR, Ravichandran KS, Uchiyama S, Santos WL, Rogers GW, Okusa MD, Bayliss DA, Hoehn KL (2014) Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane. Mol Metab 3:114–123
pubmed: 24634817
Ost M, Keipert S, Klaus S (2017) Targeted mitochondrial uncoupling beyond UCP1 - the fine line between death and metabolic health. Biochimie 134:77–85
pubmed: 27916644